Sex Differences in Low-Density Lipoprotein Cholesterol Reduction With PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry
Conclusions:
This multicentre and retrospective registry of real-world patients treated with PCSK9 inhibitors highlights significant gender differences in LDLc reduction.
Source: Journal of Cardiovascular Pharmacology - Category: Cardiology Tags: Original Article Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Drugs & Pharmacology | Heart | Statin Therapy | Statistics | Study | Vytorin | Women | Zetia